文献速递炎症性肠病

老年起病炎症性肠病的表型与自然史:一项多中心病例对照研究

Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.
PubMed 文献 · Aliment Pharmacol Ther · 2018-01-25

该多中心病例对照研究纳入1374例老年起病(>60岁诊断)与1374例成年起病(18-40岁诊断)炎症性肠病患者,比较表型特征与治疗资源使用。老年起病溃疡性结肠炎广泛病变比例较低(33% vs 39%),克罗恩病狭窄型(24% vs 13%)和结肠局限型(28% vs 16%)比例较高,穿透型较低(12% vs 19%)。老年起病者皮质类固醇、免疫抑制剂和抗TNF制剂使用显著较少,溃疡性结肠炎手术率较高(8.3% vs 5.1%),住院率(66% vs 49%)和肿瘤发生率(14% vs 0.5%)较高。

要点

  • 老年起病溃疡性结肠炎广泛病变比例低于成年起病(33% vs 39%,P<0.0001)。
  • 老年起病克罗恩病狭窄型(24% vs 13%)和结肠局限型(28% vs 16%)较多,穿透型较少(12% vs 19%)。
  • 老年起病者住院率(66% vs 49%)和肿瘤发生率(14% vs 0.5%)较高,溃疡性结肠炎手术率较高(8.3% vs 5.1%)。

核心结论

  • 老年起病炎症性肠病具有特定表型特征,且治疗管理方式不同,免疫抑制剂使用较少,溃疡性结肠炎手术率较高。

研究设计与样本

  • 多中心病例对照研究,纳入2000年以来诊断且随访超过12个月的老年起病(>60岁诊断)炎症性肠病患者,按诊断年份、性别和炎症性肠病类型与18至40岁诊断的成年起病患者匹配。

主要发现

  • 共纳入1374例老年起病和1374例成年起病病例(62%为溃疡性结肠炎,38%为克罗恩病)。
  • 溃疡性结肠炎中,老年起病广泛病变比例较低(33% vs 39%;P<0.0001)。
  • 克罗恩病中,老年起病狭窄型比例较高(24% vs 13%;P<0.0001),结肠局限型比例较高(28% vs 16%;P<0.0001),穿透型比例较低(12% vs 19%;P<0.0001)。
  • 老年起病者皮质类固醇(P<0.0001)、免疫抑制剂(P<0.0001)和抗TNF制剂(P<0.0001)使用显著较少。
  • 老年起病溃疡性结肠炎手术率较高(8.3% vs 5.1%;P<0.009),住院率较高(66% vs 49%;P<0.0001),肿瘤发生率较高(14% vs 0.5%;P<0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Onset during old age has been reported in upto 10% of total cases of inflammatory bowel disease (IBD). AIM: To evaluate phenotypic characteristics and the use of therapeutic resources in patients with elderly onset IBD. METHODS: Case-control study including all those patients diagnosed with IBD over the age of 60 years since 2000 who were followed-up for >12 months, identified from the IBD databases. Elderly onset cases were compared with IBD patients aged 18 to 40 years at diagnosis, matched by year of diagnosis, gender and type of IBD (adult-onset). RESULTS: One thousand three hundred and seventy-four elderly onset and 1374 adult-onset cases were included (62% ulcerative colitis (UC), 38% Crohn's disease (CD)). Among UC patients, elderly onset cases had a lower proportion of extensive disease (33% vs 39%; P < 0.0001). In CD, elderly onset cases showed an increased rate of stenosing pattern (24% vs 13%; P < 0.0001) and exclusive colonic location (28% vs 16%; P < 0.0001), whereas penetrating pattern (12% vs 19%; P < 0.0001) was significantly less frequent. Regarding the use of therapeutic resources, there was a significantly lower use of corticosteroids (P < 0.0001), immunosuppressants (P < 0.0001) and anti-TNFs agents (P < 0.0001) in elderly onset cases. Regarding surgery, we found a significantly higher surgery rate among elderly onset UC cases (8.3% vs 5.1%; P < 0.009). Finally, elderly onset cases were characterised by a higher rate of hospitalisations (66% vs 49%; P < 0.0001) and neoplasms (14% vs 0.5%; P < 0.0001). CONCLUSIONS: Elderly onset IBD shows specific characteristics and they are managed differently, with a lower use of immunosuppressants and a higher rate of surgery in UC.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Mañosa M, Calafat M, de Francisco R, et al. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study. Aliment Pharmacol Ther. 2018. PMID: 29369387. doi:10.1111/apt.14494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。